BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8473379)

  • 1. Growth hormone induces insulin resistance in Laron dwarf cells via lactogenic receptors.
    Geffner ME; Bersch N; Golde DW
    J Clin Endocrinol Metab; 1993 Apr; 76(4):1039-47. PubMed ID: 8473379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-lymphoblast cell lines from Laron dwarfs augment basal colony formation in response to extremely high concentrations of growth hormone.
    Geffner ME; Bersch N; Lippe BM; Golde DW
    J Clin Endocrinol Metab; 1990 Mar; 70(3):810-3. PubMed ID: 2307733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissues of the Laron dwarf are sensitive to insulin-like growth factor I but not to growth hormone.
    Geffner ME; Golde DW; Lippe BM; Kaplan SA; Bersch N; Li CH
    J Clin Endocrinol Metab; 1987 May; 64(5):1042-6. PubMed ID: 3031118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone mediates the growth of T-lymphoblast cell lines via locally generated insulin-like growth factor-I.
    Geffner ME; Bersch N; Lippe BM; Rosenfeld RG; Hintz RL; Golde DW
    J Clin Endocrinol Metab; 1990 Aug; 71(2):464-9. PubMed ID: 2380340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prolactin/growth hormone receptor family.
    Kelly PA; Djiane J; Postel-Vinay MC; Edery M
    Endocr Rev; 1991 Aug; 12(3):235-51. PubMed ID: 1935820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor I resistance in immortalized T cell lines from African Efe Pygmies.
    Geffner ME; Bersch N; Bailey RC; Golde DW
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3732-8. PubMed ID: 8530626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor I and insulin down-regulate growth hormone (GH) receptors in rat osteoblasts: evidence for a peripheral feedback loop regulating GH action.
    Leung K; Rajkovic IA; Peters E; Markus I; Van Wyk JJ; Ho KK
    Endocrinology; 1996 Jul; 137(7):2694-702. PubMed ID: 8770888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of hormone binding in COS-7 cells expressing a mutated growth hormone receptor found in Laron dwarfism.
    Edery M; Rozakis-Adcock M; Goujon L; Finidori J; Lévi-Meyrueis C; Paly J; Djiane J; Postel-Vinay MC; Kelly PA
    J Clin Invest; 1993 Mar; 91(3):838-44. PubMed ID: 8450064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific alterations in insulin-like growth factor-I concentrations in response to 3,3',5-triiodo-L-thyronine supplementation in the growth hormone receptor-deficient sex-linked dwarf chicken.
    Vasilatos-Younken R; Dunnington EA; Siegel PB; McMurtry JP
    Gen Comp Endocrinol; 1997 Jan; 105(1):31-9. PubMed ID: 9000465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
    Vaccarello MA; Diamond FB; Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Gargosky S; Cohen P; Wilson K; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts.
    Lee PD; Rosenfeld RG; Hintz RL; Smith SD
    J Clin Endocrinol Metab; 1986 Jan; 62(1):28-35. PubMed ID: 2999181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin and growth hormone in the regulation of the immune system.
    Gala RR
    Proc Soc Exp Biol Med; 1991 Oct; 198(1):513-27. PubMed ID: 1891468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I.
    Fleenor D; Arumugam R; Freemark M
    Horm Res; 2006; 66(3):101-10. PubMed ID: 16735796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I.
    Skottner A; Clark RG; Fryklund L; Robinson IC
    Endocrinology; 1989 May; 124(5):2519-26. PubMed ID: 2707163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of the plasma growth hormone-binding protein in Laron-type dwarfism.
    Baumann G; Shaw MA; Winter RJ
    J Clin Endocrinol Metab; 1987 Oct; 65(4):814-6. PubMed ID: 3654924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sex and pregnancy hormones on growth hormone and prolactin receptor gene expression in insulin-producing cells.
    Møldrup A; Petersen ED; Nielsen JH
    Endocrinology; 1993 Sep; 133(3):1165-72. PubMed ID: 8365359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone is a human macrophage activating factor. Priming of human monocytes for enhanced release of H2O2.
    Warwick-Davies J; Lowrie DB; Cole PJ
    J Immunol; 1995 Feb; 154(4):1909-18. PubMed ID: 7836772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laron-type dwarfism with apparently normal high affinity serum growth hormone-binding protein.
    Buchanan CR; Maheshwari HG; Norman MR; Morrell DJ; Preece MA
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):179-85. PubMed ID: 1934534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone induces resistance to the mitogenic action of insulin through local IGF-I. Studies in normal and Pygmy T-cell lines.
    Geffner ME; Bersch N; Bailey RC; Golde DW
    Diabetes; 1994 Jan; 43(1):68-72. PubMed ID: 8262319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Long-lived Mouse Lacking Both Growth Hormone and Growth Hormone Receptor: A New Animal Model for Aging Studies.
    Gesing A; Wiesenborn D; Do A; Menon V; Schneider A; Victoria B; Stout MB; Kopchick JJ; Bartke A; Masternak MM
    J Gerontol A Biol Sci Med Sci; 2017 Aug; 72(8):1054-1061. PubMed ID: 27688483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.